Author | Lightnews

Genedrive @genedrive.bsky.social · Aug 12

Genedrive® MT-RNR1 ID Kit is a rapid genetic test designed to be used in time critical situations, prior to antibiotic treatment prescription.

Its provides the result of an individual’s MT-RNR1 gene variant status to inform clinicians ahead of antibiotic treatment decisions, in 26 minutes.

Genedrive @genedrive.bsky.social · Aug 7

Join the genedrive team for this key event for East Midlands NHS and healthcare organisations.

📅 Sep 18th at the Nottingham Belfry Hotel
Bringing together colleagues to explore opportunities for innovation to help transform care in your areas.

Register healthinnovation-em.org.uk/component/rs...

Genedrive @genedrive.bsky.social · Jul 7

Keep an eye on the Genedrive website this week...

#GDR

6 1 1

Genedrive @genedrive.bsky.social · Jul 7

Keep an eye on the Genedrive website this week...

#GDR

Genedrive @genedrive.bsky.social · Jul 4

We had a fantastic day at the ONE BioHub Innovate MedTech North Conference yesterday!

Thank you to the event organisers and speakers for putting together an excellent event.

#GDR #innovation #diagnostics #medtech #genetics #genomics #POCT #pharmacogenetics #pharmacogenomics

1

Genedrive @genedrive.bsky.social · Jul 2

TOMORROW you can find @Gino Miele and @Stacey Gardiner at the ONE BioHub Innovate MedTech North Conference in Aberdeen!

Contact [email protected] to book a meeting.

#GDR #POCT #pointofcare #pharmacogenomics #pharmacogenetics #diagnostics #genetics

1 1

Genedrive @genedrive.bsky.social · Jun 30

Testing for CYP2C19 metaboliser status is important in ensuring patients get the right treatment at the right time.

Learn more: www.genedrive.com/assays/cyp2c...

#GDR #POCT #Cardiology #Genetics #Pharmacogenetics #Pharmacogenomics #Stroke #Diagnostics #NHS #CYP2C19

1 2

Genedrive @genedrive.bsky.social · Jun 27

This week, Genedrive CEO Dr. Gino Miele talked about the company’s progress in rapid pharmacogenetic testing for emergency care at the Proactive One2One Investor Forum.

📺 Watch now: www.youtube.com/watch?v=MrfH...

#GDR #genetics #pharmacogenetics #pharmacogenomics #diagnostics #healthcare

Genedrive CEO on rapid genetic testing rollout - One2One Investor Forum

YouTube video by Proactive Investors

www.youtube.com

1 1

Genedrive @genedrive.bsky.social · Jun 16

Not all antiplatelets work equally for everyone…

The Genedrive CYP2C19 ID Kit has recently been CE marked, and guides treatment by providing rapid, actionable genetic results.

Learn more: www.genedrive.com/assays/cyp2c...

#GDR #POCT #patientsafety #pointofcare #pharmacogenomics #pharmacogenetics

1 1

Genedrive @genedrive.bsky.social · Jun 13

CPIC guidelines recommend CYP2C19 genotyping for patients undergoing PCI.

The Genedrive CYP2C19 ID Kit provides rapid, actionable genetic results to aid clinicians in these vital decisions.

Read more: www.genedrive.com/assays/cyp2c...

#GDR #pharmacogenomics #diagnostics #genetics #genomics

1 1

Genedrive @genedrive.bsky.social · Jun 11

It’s just 1 WEEK until the #UKPGx2025 12th Annual Meeting in London!

Learn more: my.bps.ac.uk/events/detai...

#GDR #Pharmacogenetics #Genetics #Pharmacogenomics #POCT #pointofcare #diagnostics #genomics

1 1

Genedrive @genedrive.bsky.social · Jun 9

Meta-analysis found that patients with CYP2C19 variants on clopidogrel had significantly higher rates of ischaemic events after PCI.

Using the Genedrive CYP2C19 ID Kit before prescription could help reduce these risks.

Read more: www.genedrive.com/assays/cyp2c...

#GDR #pharmacogenomics #genetics

1 1

Genedrive @genedrive.bsky.social · Jun 6

Pharmacogenetics can transform how we manage ACS and PCI.

The now CE marked, Genedrive CYP2C19 ID Kit provides genetic results rapidly to inform clinicians and guide their treatment decisions.

Learn more: www.genedrive.com/assays/cyp2c...

#GDR #POCT #Stroke #patientsafety #pharmacogenomics

Genedrive @genedrive.bsky.social · Jun 4

In 2 WEEKS, we’ll be exhibiting at the Welsh Stroke Conference!

At the All Nations Conference Centre in Cardiff

Learn more: welshstrokeconference.co.uk

#GDR #POCT #Stroke #patientsafety #pointofcare #pharmacogenomics #pharmacogenetics #StrokeAwareness #Wales

Genedrive @genedrive.bsky.social · Jun 2

We are delighted that both of our pharmacogenetic tests are now available for order via the NHS supply chain!

Contact [email protected] for more information

#GDR #pharmacogenomics #pharmacogenetics #diagnostics #POCT #genetics #pointofcare #NHS

1 1 3

Genedrive @genedrive.bsky.social · May 30

We are delighted that the Genedrive CYP2C19 ID Kit has received CE-certification under the European In Vitro Diagnostics Regulation!

Read the RNS: www.genedrive.com/news/index.php

#GDR #POCT #pharmacogenomics #pharmacogenetics #diagnostics #pointofcare #stroke #cardiology #genetics #DEVOTE

1

Genedrive @genedrive.bsky.social · May 30

Every stroke can have a devastating impact on a family.

In around a third of people, clopidogrel, one of the main antiplatelet drugs, is not working effectively.

Learn how genetic testing can help: www.genedrive.com/assays/cyp2c...

1

Genedrive @genedrive.bsky.social · May 28

In ONE month we will be sponsoring the UKPGx 12th Annual Meeting in London!

Join us for an exciting day of talks around developments in the field of pharmacogenetics.

#GDR #pharmacogenomics #POCT #diagnostics #UKPGx2025

1

Genedrive @genedrive.bsky.social · May 26

Implementing the Genedrive® CYP2C19 ID Kit to guide therapy could prevent recurrent strokes and reduce healthcare costs.

Learn more on our website: www.genedrive.com/assays/cyp2c...

#StrokeAwarenessMonth #PrecisionMedicine #StrokePrevention #Pharmacogenomics #PublicHealth #GDR

1

Genedrive @genedrive.bsky.social · May 23

Clopidogrel is key in stroke therapy — but it doesn’t work for everyone.

Genotype-guided therapy, using the Genedrive® CYP2C19 ID Kit, helps identify clopidogrel-resistant patients.

Learn how: www.genedrive.com/assays/cyp2c...

#StrokeAwarenessMonth #PrecisionMedicine #Pharmacogenomics #GDR

1

Genedrive @genedrive.bsky.social · May 21

Join us on Stand D8 for day 1 of ESOC 2025 in Helsinki!

Discover how our innovative genetic test can guide antiplatelet therapy following a stroke.

Learn more: eso-stroke.org/esoc2025/

#GDR #POCT #Stroke #ESOC2025 #Pharmacogenomics

Genedrive @genedrive.bsky.social · May 19

THIS WEEK we'll be at the 11th European Stroke Organisation Conference (ESOC 2025). Visit our stand to explore genetic testing to guide antiplatelet therapy via CYP2C19 metaboliser status. Learn more: eso-stroke.org/esoc2025/
#GDR #POCT #Stroke #pharmacogenomics #StrokeAwareness #ESOC2025

Genedrive @genedrive.bsky.social · May 16

May is Stroke Awareness Month. 1 in 4 will experience a stroke, the second leading cause of death and third for combined death and disability worldwide.

Visit our website to see how we’re tackling this challenge: www.Genedrive.com/assays/cyp2c19

#GDR #StrokeAwarenessMonth #StrokePrevention

1 1

Genedrive @genedrive.bsky.social · May 14

Genedrive will be showcasing their innovations at the POCT Innovators Clinical Innovation EXPO tomorrow!

Reach out to [email protected] to arrange a meeting.

#GDR #POCT #pointofcare #pharmacogenomics #pharmacogenetics #diagnostics #genetics #innovation

Genedrive @genedrive.bsky.social · May 13

The Genedrive CYP2C19 ID Kit is being used in a trial led by @mftnhs.bsky.social in collaboration with the Genotype Guided Primary Coronary Intervention programme and the BHF Centre of Excellence!

Read more: www.genedriveplc.com/press-releas...

#GDR #cardiology #genetics #clopidogrel

1